Serum institute
- Middle East
Made-in-India COVID-19 vaccines in Yemen a ‘game changer’: UN official
United Nations: The shipment of 360,000 Made-in-India COVID-19 vaccines that arrived in Yemen, as part of the first batch of 1.9 million doses it will receive throughout the year, is a “game changer”…
- Top Stories
President, PM Modi express grief after 5 die in Serum Institute fire incident
New Delhi: President Ram Nath Kovind on Thursday expressed grief over the demise of five people who lost their lives in the fire incident at Serum Institute of India (SII), in Pune.…
- Top Stories
Fire in Serum Institute; Covishield facility not affected
Pune: Three persons were evacuated from a building in the Serum Institute of India’s Manjari premises here after a fire broke out there on Thursday, police said. There is no impact on…
- Top Stories
First shipment of Covishield vaccine arrives in Hyderabad
Hyderabad: Finally the wait is over as much-awaited COVID-19 vaccine has reached Hyderabad. On Tuesday morning the first shipment of ‘Covishield’ vaccine has reached Rajiv Gandhi International Airport at Shamshabad. After the…
- Top Stories
Scientists-doctors forum demand rollback of nod to COVID vaccines
New Delhi: The Progressive Medicos and Scientists Forum have demanded the rollback of approvals for emergency use authorisation given to two vaccine candidates by the Drug Controller General of India (DCGI). “Science can’t…
- India
Coronavirus vaccine to cost $3-4 to govt; $6-8 in pvt mkt: Serum
New Delhi: Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD 3-4 per shot (Rs 219-292) to the government and will be priced at double that rate in private…
- Top Stories
DCGI approves SII’s ‘Covishield’, Bharat Biotech’s ‘Covaxin’ Vaccines
New Delhi: India’s drug controller Drugs Controller General of India(DCGI) has approved Serum Institute of India’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ for restricted emergency use. This was informed by Dr VG Somani,…
- News
India-made COVID-19 vaccines to give supply edge: Bill Gates
With a lot of factories based in India — including AstraZeneca and Johnson & Johnson — in the race for manufacturing a COVID-19 vaccine, they hold an edge for public distribution and…
- India
Serum Institute to manufacture 200M doses of Covid-19 vaccine
New Delhi: A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will accelerate the manufacture and…
- India
India trials of COVID-19 vaccine going on: Serum Institute
New Delhi: Serum Institute of India (SII) on Wednesday said it is continuing with the trials of AstraZeneca’s COVID-19 vaccine candidate in India. The statement came after AstraZeneca announced that late-stage studies of…
